Area of research
Molecular Biology · Oncology
Research interest
Research focused on Cancer research and Breast cancer, with related work in Kinome, Enzalutamide, KRAS. Notable publications include 'Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer', 'Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease', and 'Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells'.
Long-Term Latency of Highly Mutated Cells in Normal Mouse Skin Is Reversed by Exposure to Tumor Promoters and Chronic Tissue Damage
Targeting KRAS4A splicing through the RBM39/DCAF15 pathway inhibits cancer stem cells
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer
Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer
Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer